Ind-Swift Laboratories logo

Ind-Swift Laboratories financials and balance sheet

NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap

Last close ₹327.45down ₹17.90 (5.18%)BSE ₹327.80

Share price at the NSE close on 23 Oct 2026. Previous close ₹345.35.

52-week range of traded prices to 23 Oct 2026
₹87.15Low, 31 Dec 2025₹424.75High, 30 Sep 2026
Market cap
₹2,848 Cr1,404th largest listed
P/E
49.7
P/E without one-offs
41.5
P/B
2.1
Dividend yield
Nonein the last 12 months
ROE
4.5%
ROE without one-offs
5.4%
ROCE
2.0%
Debt to equity
0.01
Volume, NSE
6,58,24852.8% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Ind-Swift Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 4 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out.

The years either side of a change of basis do not compare. From the year to Mar 2025, the company's revenue for that year, ₹562 Cr, differs from its quarters added, ₹192 Cr. From the year to Mar 2026, the company's revenue for that year, ₹641 Cr, differs from its quarters added, ₹626 Cr.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue641
  2. Materials and goods−282
  3. Employee costs−138
  4. Other expenses−176
  5. Operating profit45
  6. Depreciation−31
  7. Other income+47
  8. One-off items−11
  9. Finance costs−1.4
  10. Profit before tax49
  11. Tax−7.7
  12. Joint ventures+0.1
  13. Net profit41

What the company owns

  • Plant, investments and other assets₹885 Cr
  • Cash and bank₹430 Cr
  • Receivables₹199 Cr
  • Inventory₹148 Cr
  • Current investments₹12 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,384 Cr
  • Owed to suppliers₹146 Cr
  • Other liabilities₹126 Cr
  • Borrowings₹18 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Ind-Swift Laboratories quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 11 JunMar 2020Filed 22 JunMar 2021Filed 5 JulMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 15 MayMar 2025Filed 12 AugMar 2026Filed 28 May
Revenue from operations7187657577808911,0391,2071,281562641
5926326206357098429781,027581596
Materials and goods bought359394398397451527656661288282
Employee costs–9294103107114136153118138
Other expenses–146129136151201187212176176
Operating profit before depreciation127134136144183196229254−1945
Operating margin17.6%17.5%18.0%18.5%20.5%18.9%19.0%19.8%−3.5%7.0%
Materials, % of revenue–51.4%52.6%50.9%50.6%50.7%54.3%51.6%51.3%44.0%
Employee costs, % of revenue–12.0%12.4%13.2%12.0%11.0%11.3%11.9%20.9%21.5%
Other expenses, % of revenue–19.1%17.0%17.4%16.9%19.4%15.5%16.6%31.3%27.4%
Depreciation and amortisation8887104908713157532431
Operating profit after depreciation384732549665172201−4414
Other income0182733234334458147
Finance costs90288310710096925131
Profit before one-off items and tax−5237−24−2018131131953560
One-off items−3−183000−27387223−11
Profit before tax−553659−2018138758225849
−1614211211539–78
Share of profit of joint ventures and associates0–––––0–00
Net profit−392238−21−3−24842125041
Other comprehensive income––00−200017−1
Total comprehensive income––39−21−5−34842226841
Net margin−5.4%2.9%5.1%−2.7%−0.4%−0.2%3.9%32.9%44.6%6.5%
Net margin without joint ventures and associates−5.5%–––––4.0%–44.6%6.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank. Tax is left blank for the year to Mar 2024: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown. Share of profit of joint ventures and associates is left blank for the year to Mar 2024: the filing states 0 for this share both for the period and for the year so far, which the form also writes for a line it does not fill, while the company's other filings for the same year show it was not 0 over those months.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 11 JunMar 2020Filed 22 JunMar 2021Filed 5 JulMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 15 MayMar 2025Filed 12 AugMar 2026Filed 28 May
6046416036016829311,1731,384
6046416046016829311,1731,384
Share capital4860606060596987
Reserves5565815445416228721,1041,297
Belonging to outside owners of subsidiaries––000000
1,0581,0311,005953862174118
331323315335371221221255
980906901865771124535
1,9141,8701,8181,8011,8241,1651,4381,673
1,0881,007874724660504573697
8278639441,0741,165661865977
Net debt1,0281,020993932843−415−427−424
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 5 JulMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 15 MayMar 2025Filed 12 AugMar 2026Filed 28 May
135150195−181−25−63
134150201−18514−63
−63−74−51−476−45−103
Receivables−38−26−37−13097−40
Inventories−33−53−1033−43−34
Other working capital85−5−379−99−29
Tax paid1000−30
Interest paid0000390
Capital spending41813456488
Free cash flow131132182−225−90−151
−105−13−104−110−73
−124−141−18669969142
Dividends paid000000
Shares bought back000000
Shares issued000093163
Net change in cash114−4414−666
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Ind-Swift Laboratories dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 11 JunMar 2020Filed 22 JunMar 2021Filed 5 JulMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 15 MayMar 2025Filed 12 AugMar 2026Filed 28 May
Earnings per share−₹9.20₹4.86₹10.28−₹4.28−₹0.53−₹0.36₹8.06₹71.24₹37.25₹4.95
Diluted earnings per share−₹9.20₹4.86₹8.13−₹4.28−₹0.53−₹0.36₹8.06₹71.24₹35.21₹4.84
Book value per share––₹126.96₹108.42₹102.14₹101.71₹115.41₹157.64₹170.63₹159.38
Shareholder yield––––0.0%0.0%0.0%0.0%−18.2%−14.3%
Market cap at the year end (₹ crore)151257187974253943265925091,140

Ratios

Consolidated, years to March.Ind-Swift Laboratories PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 11 JunMar 2020Filed 22 JunMar 2021Filed 5 JulMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 15 MayMar 2025Filed 12 AugMar 2026Filed 28 May
Revenue growth7.6%6.6%−1.2%3.0%14.3%16.5%16.2%6.1%––
Operating profit growth3.2%5.6%1.9%6.0%26.6%7.4%16.7%10.9%––
Net profit growth––75.4%––––785.5%–−83.5%
Earnings per share growth––111.5%––––783.9%–−86.7%
––6.4%−3.4%−0.5%−0.4%7.4%52.2%23.8%3.2%
–––−9.8 pts2.9 pts0.1 pts7.8 pts44.8 pts−28.4 pts−20.6 pts
From the net margin–––−9.8 pts3.0 pts0.2 pts7.2 pts54.5 pts18.6 pts−20.4 pts
From asset turnover–––−0.1 pts−0.1 pts−0.1 pts1.1 pts17.7 pts−35.2 pts−0.2 pts
From borrowing–––0.1 pts0.0 pts0.0 pts−0.5 pts−27.4 pts−11.8 pts−0.1 pts
Return on capital employed––1.9%3.2%5.9%4.2%11.1%21.2%−3.6%1.0%
Cash conversion––––––408.9%−42.9%−10.2%−152.5%
Interest cover0.41.70.40.51.00.71.93.9–10.3
Debt to equity––1.751.611.671.591.260.020.030.01
Receivable days––16918617716015348107113
Inventory days––3023153042972446145191
Payable days––11612411212211452140188
Cash conversion cycle, days––3553773693352832112116
Working capital days––2703133032892674125163
Asset turnover––0.400.410.480.570.670.860.430.41
Assets per rupee of net worth––3.173.042.963.002.831.851.241.22
Sales per rupee of plant––0.910.981.211.662.07238.802.162.33
Capital spending to depreciation––––0.040.140.220.842.632.87
Plant being built, % of plant in use––1.5%0.5%1.5%1.5%1.3%––3.7%
Interest cover is left blank for the year to Mar 2025: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth, net profit growth and earnings per share growth are left blank for the year to Mar 2025: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Revenue growth is left blank for the year to Mar 2026: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
2.7%
Cash from operations against operating profit
−140.1%
Measure10 years5 years3 years
Revenue growth, yearly rate−0.4%−6.4%−19.0%
Profit growth, yearly rate––−4.5%
Return on equity, average–17.3%26.4%
Return on capital employed, average–6.8%6.2%
Operating margin, average15.3%12.3%7.8%
Net margin, average8.7%17.5%28.0%
Asset turnover, average–0.590.57
Cash conversion cycle, days, average–17077
Interest cover, average2.34.27.1
Debt to equity, average–0.580.02

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations75−270−63
Cash from investing−295−287−73
Cash from financing583910142
Capital spending22819788
Dividends paid000
Shares bought back000
Shares issued for cash256256163
Borrowings raised28280
Borrowings repaid1415915

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––777633
Altman Z-scorePublished threshold 1.81–1.441.411.751.892.165.913.914.45
Beneish M-scorePublished threshold −1.78–––−2.93−2.99−2.714.38−0.26−1.99
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––−6.94−8.69−7.3747.2829.6211.39
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––11.340.35−0.02−0.38
Receivables growth less revenue growthOur threshold 0 percentage points––9.95−5.26−11.36−5.12−72.6353.436.51
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––4.39−4.23−2.58−22.14−98.511,048.2631.47
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––−0.461.274.342.72−11.9312.3910.80
Assets under construction, years of additionsOur threshold 2 years of additions––0.070.390.400.59––0.22
Effective tax ratePublished threshold 17.16 per cent39.0035.03–117.48117.1544.7226.002.8215.76
Tax charged less tax paid, % of profitOur threshold 10 percentage points––––117.1544.4725.991.5215.76
A threshold marked as ours has no published figure; it is the line we read the check against.